Compare DHY & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DHY | BTMD |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.3M | 80.4M |
| IPO Year | N/A | N/A |
| Metric | DHY | BTMD |
|---|---|---|
| Price | $1.99 | $2.78 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 569.1K | 119.8K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 9.10% | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | N/A | ★ 0.78 |
| Revenue | N/A | ★ $195,645,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.80 |
| P/E Ratio | ★ N/A | $3.57 |
| Revenue Growth | N/A | ★ 1.34 |
| 52 Week Low | $1.77 | $2.32 |
| 52 Week High | $2.08 | $6.36 |
| Indicator | DHY | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 28.31 | 55.29 |
| Support Level | $1.98 | $2.58 |
| Resistance Level | $2.02 | $2.90 |
| Average True Range (ATR) | 0.02 | 0.13 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 6.25 | 69.51 |
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.